Current view and outcome of ITI therapy - A change over time?
Makaleler > Tam Makale · 2016
Yazarlar: K. HOLSTEIN, A. BATOROVA, M. CARVALHO, K. FIJNVANDRAAT, P. HOLME, Ramazan Kaan KAVAKLI, T. LAMBERT, A. ROCINO, V. JIMENEZ-YUSTE, J. Astermark
Thrombosis Research, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Wos, 2016, cilt 148, ss 38-44
DOI: 10.1016/j.thromres.2016.10.015
Özet
Introduction: Inhibitor development in people with haemophilia is a serious complication that may require intensive and costly interventions. The goal of inhibitor management should be permanent inhibitor eradication through immune tolerance induction (ITI), but well-designed studies are lacking and the management of patients is therefore defined by the experience and views of the clinician.